跳到主要导航 跳到搜索 跳到主要内容

Antiatherogenic effect of pioglitazone on uremic apolipoprotein E knockout mice by modulation of the balance of regulatory and effector T cells

  • Yan Shen
  • , Zuyi Yuan
  • , Aiping Yin
  • , Yan Liu
  • , Yan Xiao
  • , Yue Wu
  • , Lijun Wang
  • , Xiao Liang
  • , Yan Zhao
  • , Yuling Tian
  • , Weimin Liu
  • , Tao Chen
  • , Chiharu Kishimoto
  • Xi'an Jiaotong University
  • Kyoto University

科研成果: 期刊稿件 › 文章 › 同行评审

15 引用 (Scopus)

摘要

Objective: Uremia markedly accelerates atherogenesis, but the pathogenesis remains to be elucidated and effective anti-atherogenic treatments are needed. The aim of this study was to investigate the relationship between accelerated atherosclerosis (AS) and the balance of regulatory/effector T cells (Treg/Teff) in uremic apolipoprotein E knockout (apoE-/-) mice, and the effect of pioglitazone on uremic AS and possible mechanisms. Methods and results: Uremia was induced surgically in 8-week-old male apoE-/- mice. Two weeks after induction of uremia, the mice were randomized to receive pioglitazone (daily oral gavage with 20. mg/kg) or vehicle. Control apoE-/- mice were sham-operated and received vehicle. After 8 weeks' treatment, all mice were sacrificed. The cross-sectional area of atherosclerotic lesions at the aortic root was significantly larger and plaques were unstable in uremic mice, which was associated with a Treg/Teff imbalance (Treg down-regulated/Teff up-regulated) compared with controls. Renal function and the percentage of Treg cells in splenocytes were negatively correlated in control and uremic mice that received vehicle. Treatment with pioglitazone dramatically inhibited AS progression, stabilized plaque and modulated the Treg/Teff imbalance (up-regulated Treg/down-regulated Teff) in uremic mice, without influencing serum lipid profiles and blood glucose. In vitro, oxidized low density lipoprotein induced a Treg/Teff imbalance in splenocytes from uremic mice. Pioglitazone modulated the imbalance by upregulating Treg cells and downregulating Teff cells. The former was not abolished by the peroxisome proliferator-activated receptor (PPAR)γ antagonist GW9662, whereas the latter was completely abolished by GW9662. Conclusion: Pioglitazone ameliorates accelerated AS in uremic apoE-/- mice, probably through PPARγ-independent and -dependent mechanisms to modulate the Treg/Teff imbalance.

源语言英语
页(从-至)330-338
页数9
期刊Atherosclerosis
卷218
期2
DOI
出版状态已出版 - 10月 2011

学术指纹

探究 'Antiatherogenic effect of pioglitazone on uremic apolipoprotein E knockout mice by modulation of the balance of regulatory and effector T cells' 的科研主题。它们共同构成独一无二的学术指纹。

引用此